Lausanne is a US-based company that takes great pride in producing high quality small molecule API and advanced intermediates. Lausanne has a number of facilities to meet all of your production and process development needs. Our resources are focused on helping our clients advance new drugs to market fast!
We demonstrate our on bench scale in our R&D Labs. Typically small-scale requirements are fulfilled with no additional R&D work! For larger requirements, additional development work is done as needed to support production in fixed equipment.
We have five kilo-lab suites for small-scale cGMP clinical requirements. Equipment capacity ranging from glassware scale to 200 Liters.
Your intermediate-scale clinical API needs will be made using our Pilot Plant in Florence.
Lausanne will support your clinical program from development through market Our Greenville site is used to manufacture your APIs for late clinical requirements, launch, and ongoing commercial requirements. Registration and Validation batches are routinely produced to support your regulatory submission.
Lausanne has state-of-the-art facilities to handle process R&D, clinical supply, and commercial requirements for high potency and cytotoxic compounds. Our commercial GMP suite was designed to meet SafeBridge Level 4 status. Our capabilities include:
In addition to extensive experience in the ß-Lactam field, Lausanne is one of the only companies in the US to have a dedicated stand-alone facility to handle process R&D and early clinical supply requirements.
Lausanne is licensed by the DEA to handle and produce controlled substances. |
||
Our Vision| Company Profile| Capabilities| API Activity | ||